FACULTAD DE MEDICINA
FACULTAD
![Foto de FACULTAD DE MEDICINA](/img/noimage.png)
![Foto de Memorial Sloan Kettering Cancer Center](/img/noimage_org.png)
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (23)
2024
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
OncoImmunology, Vol. 13, Núm. 1
-
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
Annals of Oncology, Vol. 35, Núm. 2, pp. 159-182
2022
-
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Familial Cancer, Vol. 21, Núm. 2, pp. 211-227
2021
-
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project
Blood Advances, Vol. 5, Núm. 3
2020
2018
-
Prediction of acute myeloid leukaemia risk in healthy individuals
Nature, Vol. 559, Núm. 7714, pp. 400-404
2016
-
The impact on survival of an extensive sex cord-like component in mullerian adenosarcomas: A study comprising 6 cases
International Journal of Gynecological Pathology, Vol. 35, Núm. 2, pp. 147-152
2014
-
Reproducibility of current classifications of endometrial endometrioid glandular proliferations: Further evidence supporting a simplified classification
Histopathology, Vol. 64, Núm. 2, pp. 284-292
2011
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
The Lancet, Vol. 378, Núm. 9793, pp. 771-784
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
The Lancet, Vol. 378, Núm. 9793, pp. 771-784
2010
-
Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1
BMC Molecular Biology, Vol. 11
2009
-
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma
Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 51, pp. 21830-21835
-
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
BMC Cancer, Vol. 9
2007
-
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma
Genes Chromosomes and Cancer, Vol. 46, Núm. 4, pp. 385-396
2005
-
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma
Cancer Research, Vol. 65, Núm. 7, pp. 2565-2571
-
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma
Cancer Immunology, Immunotherapy, Vol. 54, Núm. 4, pp. 400-406
-
Prognostic value of MYCN and ID2 overexpression in neuroblastoma
Pediatric Blood and Cancer, Vol. 45, Núm. 7, pp. 909-915
2004
-
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma
Journal of the National Cancer Institute, Vol. 96, Núm. 16, pp. 1208-1219
-
Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours
British Journal of Cancer, Vol. 91, Núm. 6, pp. 1112-1118
-
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas
Cancer Genetics and Cytogenetics, Vol. 154, Núm. 2, pp. 131-137